gen tirz tirzepatide 💊 — Mechanism of Action & Pharmacokinetics 👨‍⚕️ Mechanism of Action • Tirzepatide is the first dual GIP/GLP-1 receptor agonist. • Activates both: - Glucose-Dependent Insulinotropic Polypeptide (GIP) receptors Compounded Tirzepatide Weight Loss Program

Learn why it happens and practical ways to manage it.

Alex Goldmark is Planet Moneys executive producer.Listen free at these links: Apple Podcasts, Spotify, the NPR app or anywhere you get podcasts.Find more Planet Money: Facebook / Instagram / TikTok / Our weekly Newsletter.Help support Planet Money and hear our bonus episodes by subscribing to Planet Money+ in Apple Podcasts or at plus.npr.org/planetmoney.Music: Source Audio - Subtly Silly Thug, Got The Moves, and Vive le Punk

In a study of more than 1,600 adults with type 2 diabetes, those who received the highest dose of orforglipron on average shed 10.5% of their weight.

Tirzepatide ()

While industry should not ignore this emerging threat, there is plenty of opportunity for sensible, evidence-based innovation tailored to support GLP-1 users.